COVID VACCINE RESULTS
Self-amplifying RNA COVID-19 vaccine technology safe in humans, suggests study
Results from the first trial of a new COVID-19 vaccine technology show no short-term safety concerns.
Stories tagged with 'vaccines'
VGH winding up
VacEquity Global Health (VGH)
Imperial and its partners are closing VacEquity Global Health (VGH).
Malaria vaccines at scale
‘Mosquito smoothie’ innovation boosts future malaria vaccine potential
A faster method for collecting pure malaria parasites from infected mosquitos could accelerate the development of new, more potent malaria vaccines.
1
Vaccine manufacturing
Next generation vaccine tech offers post-COVID opportunities – global experts
The Imperial-led Future Vaccine Manufacturing Research (FVMR) Hub co-hosted an event with the Vax-Hub on what we have learnt from COVID-19.
COVID-19 vaccination
COVID-19 global vaccination programme: the challenges ahead
Vaccine experts from around the world spoke about the challenges of the COVID-19 global rollout at a special webinar event.
Feature
CLINICAL TRIALS DAY
How Imperial’s clinical researchers rose to the challenge of vaccine trials
We speak to Imperial's Clinical Research Facility on how they adapted their work during the pandemic to deliver several COVID-19 vaccine trials.
Vaccine hesitancy
COVID-19 vaccine hesitancy could lead to thousands of extra deaths
Hesitancy around COVID-19 vaccines could lead to thousands of extra deaths over a two-year period, Imperial epidemiologists show.
COVID DIALYSIS STUDY
New study to explore how well COVID-19 vaccines protect dialysis patients
A new study will assess how well COVID-19 vaccines work in people who attend hospital for their dialysis treatment (haemodialysis).
Investing in RNA
UK must invest to keep up with RNA vaccine revolution – Robin Shattock
Professor Robin Shattock says the UK needs to invest more in RNA vaccine technology to better prepare us for future pandemics.
Vaccine boost
Single dose of vaccine acts as ‘booster’ in those with prior COVID-19 infection
Two new studies have revealed insights into the immune protection provided by a single dose of COVID-19 vaccination.
